Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for cancer treatment. Its structure supports binding to enzyme active sites, enhancing selectivity and potency. Also employed in research for designing novel antimicrobial and anti-inflammatory agents due to its ability to modulate biological pathways. The bromo and trifluoromethyl groups allow further functionalization through cross-coupling reactions, making it valuable in medicinal chemistry for building complex drug-like molecules.